Antigen-specific effector CD8 + T cells play a critical role in controlling hepatic infections, such as the one caused by hepatitis B virus (HBV). We review here recent results where we coupled advanced dynamic imaging with dedicated mouse models of HBV pathogenesis to show that circulating effector CD8 + T cells aimed at viral clearance initially arrest in liver sinusoids by preferentially docking onto platelets that have previously adhered to liver sinusoids. Upon detachment from platelets, effector CD8 + T cells crawl within the sinusoids irrespective of bloodstream direction, and probe underlying hepatocytes for the presence of antigen by extending filopodia-like protrusions through the sinusoidal fenestrae. Effector CD8 + T cells recognize hepatocellular antigen and perform effector functions (i.e., IFN-c production and hepatocyte killing) while still in the intravascular space. They later extravasate in the parenchyma. Finally, we provide our perspective on how, in the next few years, intravital microscopy might shed new light on yet unresolved issues with particular regard to identifying the determinants of hepatic effector CD8 + T cell trafficking, antigen recognition and effector functions during hepatocellular carcinoma and understanding the mechanisms whereby intrahepatic T cell priming induces functionally defective T cell responses. A better understanding of how adaptive immunity mediates pathogen clearance and tumor elimination may lead to improved vaccination and treatment strategies for immunotherapy of infectious diseases and cancer. Ó Fig. 3. Cell tracks in an intravital multiphoton microscopy movie in the liver of a hepatitis B virus (HBV) replication-competent transgenic mouse. Transferred with antigen-specific (green) or antigen non-specific (red) T cells. Scale bars represent 50 lm.
Introduction
CD8 + T cells play critical roles in immune defense against infections and tumors that affect the liver. The protective capacity of these cells is mediated by antigen (Ag)-experienced effector cells and relies on their ability to migrate to and traffic within the liver, recognize pathogen-or tumor-derived antigens, get activated and deploy effector functions.
While some of the rules that characterize hepatic CD8 + T cell behavior have been characterized at the population level [1] [2] [3] [4] , we have only limited knowledge on the precise dynamics whereby CD8 + T cells migrate, interact and carry out their effector functions in the infected and cancerous liver at the single-cell level [5, 6] . What is the spatial and temporal character of such interactions? What are the molecular mechanisms that regulate CD8 + T cell communication with liver cells? How does a CD8 + T cell's prior history affect its interactive behavior? How does interactive behavior influence immunological outcome?
New advances in photonics and imaging technologies now enable us to answer these questions in living animals. We have recently implemented several advanced imaging techniques (including epifluorescence and multiphoton intravital microscopy, and correlative light and electron tomography [5] ) that allow us to dissect the interaction dynamics of CD8 + T cells within the mouse liver [7] . Such techniques, combined with a broad range of other experimental strategies, have permitted the unraveling of a unique and novel mode whereby effector CD8 + T cells exert immune surveillance toward hepatocytes that replicate the hepatitis B virus (HBV) [7] . We will review here our current understanding of the functional biology of hepatic CD8 + T cells in the context of HBV pathogenesis. We will also discuss unresolved issues and areas for future research, and highlight possible therapeutic implications. home to the liver in mouse models of acute HBV infection [8] (in which -like in HBV-infected humans or chimpanzees -the expression of individual viral proteins or of all viral gene products leading to HBV replication occurs exclusively and noncytopathically in hepatocytes). As shown in Fig. 1 , the mouse models in question are: i) transgenic mice that express only the hepatitis B core protein (containing the HBcAg determinant) in 100% of the hepatocytes [9] ; ii) replicationcompetent mice that express the entire HBV genome in 70-80% of the hepatocytes [10] ; and iii) normal inbred mice infected with low doses of either a hepatotropic adenovirus (Ad) encoding all HBV gene products and green fluorescent protein (GFP) (Ad-HBV-GFP) [11] or hepatotropic adenoassociated viruses (AAV) encoding HBcAg and eGFP (AAV-HBc-GFP) [7] . These mouse models have been used as recipients of bona fide effector CD8 + T cells that are specific for either HBcAg or hepatitis B surface Ag (HBsAg) and that are differentiated in vitro or in vivo from splenic naïve CD8 + T cells of Cor93 or Env28 TCR transgenic mice, respectively [3, 7] . Cor93 CD8 + T cells are H2 b -restricted and express the congenic marker CD45.1 [3] ; Env28 CD8 + T cells are H2 d -restricted and express the congenic marker Thy.1.1 [3] . Simultaneous injection of fluorescent Cor93 and Env28 effector CD8 + T cells into HBV replication-competent transgenic recipients expressing either H2 b or H2 d and subjected to epifluorescence intravital microscopy shows that both MHC-matched and MHC-mismatched effector CD8 + T cells accumulate at identical peak levels in the liver 2 h after injection, time point after which neither cell population is still circulating throughout the hepatic vasculature [7] . Virtually all effector CD8 + T cells that accumulate in the organ during the 2 h time frame arrest in sinusoids (atypical capillaries lined by liver sinusoidal endothelial cells [LSEC], lacking a basement membrane and containing abundant fenestrae of up to 200 nm in diameter), and they do so in an abrupt manner (i.e., without showing any prior rolling) [7] . This is consistent with previously published literature that found neutrophil adhesion in response to a chemotactic stimulus to occur within liver sinusoids in the absence of any notable rolling [12] . In an effort to explain mechanistically how effector CD8 + T cells home to the liver, we found that their arrest and early accumulation occur independently of a variety of molecules (i.e., selectins, Gai-coupled chemokine receptors, b2and a4-integrins, platelet-endothelial cell adhesion molecule [PECAM]-1 and vascular adhesion protein [VAP]-1) known to regulate effector CD8 + T cell homing in other organs and tissues [7] . Unexpectedly, the hepatic arrest of the majority of these cells relies on a mechanism that involves a docking event onto platelets that have previously adhered to LSEC [7] ( Fig. 2) , results that fit with our prior identification of platelets as critical mediators of T cell-induced liver immunopathology [4, 13, 14] .
Indeed, we were surprised to find transient platelet adhesion and aggregation within liver sinusoids even under non-inflamed conditions and thought initially that this might reflect some damage induced by the surgical preparation required to perform intravital microscopy. The detection of identical numbers of platelets aggregates in histological liver sections from mice that either underwent surgery and were subjected to intravital imaging or that were left untreated, though, ruled out this hypothesis (unpublished observations). Transient platelet adhesion and aggregation to liver sinusoids under steady-state conditions has been observed by other investigators as well [15] . This is consistent with the relatively high constitutive sinusoidal expression of hyaluronan, which we identified as a key ligand supporting platelet adhesion via CD44 [7] . Platelets have been recently shown to firmly adhere to bacterially-infected Kupffer cells (the liver-resident intravascular macrophages), thus averting systemic bacterial dissemination [15] . By contrast, we failed to observe preferential platelet adhesion on Kupffer cells in models of HBV pathogenesis, where Kupffer cells are neither infected with bacteria nor the target
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Ad -HBV-GFP or AAV-HBc -GFP of CD8 + T cells. Accordingly, Kupffer cell depletion did not alter hepatic effector CD8 + T cell accumulation in these mouse models [16] .
It will be important to determine in future studies whether this transient platelet adhesion to endothelial cells is unique to the liver, or whether it occurs in other organs as well. Although far fewer platelet-endothelial cell interactions were observed in the skin, muscle or central nervous system [15] , no studies have thus far analyzed organs with sinusoidal endothelium (e.g., spleen, bone marrow).
Reduction of platelet counts from $10 6 platelets/ ml to less than 2 Â 10 4 platelets/ml by anti-GP-Iba depleting antibodies diminished the hepatic accumulation of effector CD8 + T cells by only $50% [7] . These results suggest that either we have far more circulating platelets than are required for the efficient homing of effector CD8 + T cells to the liver or that some effector CD8 + T cells arrest within liver sinusoids in platelet-independent manner. Experiments where we blocked CD44-hyaluronan interaction in platelet-depleted animals failed to further decrease hepatic effector CD8 + T cell homing [7] , thus favoring the latter hypothesis.
While we have unmistakably identified CD44 and hyaluronan as molecular mediators of the interaction between platelets and LSEC [7] , the mechanisms by which effector CD8 + T cells dock onto platelets remain unsolved. Furthermore, a significant proportion ($40-50%) of effector CD8 + T cells adhere to LSEC in a platelet-independent fashion [7] . Although the molecular mechanisms underlying the abovementioned observations are yet-to-be discovered, an attractive hypothesis that we are currently investigating in collaboration with Gabriele Dubini at the Politecnico di Milano School of Engineering is that flow dynamic properties (e.g., pressures and shear stresses) influence the capacity of circulating effector CD8 + T cells to interact with platelets or LSEC.
Antigen recognition and effector function
Additional advanced imaging (including correlative light confocal and transmission electron microscopy and multiphoton intravital microscopy) uncovered a series of hitherto unrecognized events taking place after the initial docking of effector CD8 + T cells on platelet aggregates (Fig. 2) . First, both MHCmatched and MHC-mismatched effector CD8 + T cells start to actively crawl along liver sinusoids regardless of bloodstream direction at an average speed of $10 lm/min [7] (note that blood flows in sinusoids is 500 to 1000 fold faster, at a speed of 100-400 lm/sec [17] ). Second, correlative light and electron microscopy and subsequent tomographic reconstructions indicated that both cell populations extend ''filopodia-like" protrusions through the sinusoidal fenestrae, allowing effector CD8 + T cells to contact the basolateral membrane of underlying hepatocytes [7] . Third, MHC-matched (but not MHC-mismatched) effector CD8 + T cells cease to crawl when they get adjacent to hepatocytes expressing cognate antigen [7] . That cessation of intrasinusoidal crawling is dictated by proximity to antigen-expressing hepatocytes is also suggested by liver multiphoton intravital microscopy experiments
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Hyaluroan IFNγ HBV Hepatocytes Sinusoidal fenestrae in which Env28 and Cor93 effector CD8 + T cells are co-transferred in transgenic mice that express HBcAg alone in 100% of hepatocytes; there, Env28 effector CD8 + T cells crawled within liver sinusoids incessantly, while most of Cor93 effector CD8 + T cells remained immotile, or moved much more slowly and had a confined motility [7] (Fig. 3) . Fourth, MHC-matched effector CD8 + T cells halting intravascularly recognize hepatocellular antigens, produce IFN-c and kill antigen-expressing hepatocytes in a diapedesis-independent manner, that is, by remaining inside sinusoidal vessels and extending trans-sinusoidal protrusions [7] . Overall, these four pieces of data highlight the importance of intravascular effector CD8 + T cell crawling as this behavior -occurring irrespective of the presence of cognate antigen and ceasing after antigen recognition -represents a form of immune surveillance toward infected hepatocytes. As mentioned above, molecules such as selectins, Gai-coupled chemokine receptors, or b2and a4-integrins have been shown not to mediate the initial arrest of circulating effector CD8 + T cells. However, whether these or other potential candidates control effector CD8 + T cell crawling remains unknown. Pertinent to this, others have shown that CD1d-restricted natural killer T cells (NKT) cells patrolling the liver crawl multi-directionally along the sinusoids in a CXCR6-dependent manner [18] . Related studies looking at the way monocytes or neutrophils crawl intravascularly in other tissues have involved a role for LFA-1, CX3CR1 and Mac-1 in this process [19, 20] .
The data described above also suggest that the antigen-probing activity of effector CD8 + T cells that crawl along sinusoids requires not only the constant formation of ''filopodia-like" protrusions, but also the constant retraction of such subcellular formations. This concept might seem at odds with the notions that effector CD8 + T cells crawl at an average speed of $10 lm/min [7] and that similar migration rates have been attributed to naïve T cells moving in lymph nodes independently of transendothelial protrusions [21] [22] [23] . The high variability among crawling velocities of individual effector CD8 + T cells (between 1 and up to 30 lm/min [7] ), however, is compatible with the hypothesis that slower cells are more active in extending and retracting trans-endothelial protrusions than faster-moving ones. Experiments attempting to link the crawling behavior of individual effector CD8 + T cells with the capacity of these cells to extend/ retract protrusions are currently underway in our lab.
The idea that circulating leukocytes can interact with hepatocytes through endothelial fenestrations has been suggested before [18, 24, 25] . Our recent results reveal that this process has functional significance, as reducing sinusoidal porosity (a process referred to as defenestration) or creating a physical barrier between sinusoidal fenestrae and hepato-cellular membranes (referred to as capillarization) inhibit hepatocellular antigen recognition by effector CD8 + T cells. These results also suggest a potential mechanism whereby liver fibrosis (a condition promoting both sinusoidal defenestration and capillarization) might reduce effector CD8 + T cellmediated immune surveillance toward infected or transformed hepatocytes and, in the latter case, favor the development and progression of hepatocellular carcinoma.
Confocal immunofluorescence and flow cytometric analyses assessing the anatomical location, number and function of MHC-matched and MHC-mismatched effector CD8 + T cells isolated from the liver of HBV replication-competent transgenic mice at 2 or 4 h after transfer demonstrated that only MHC-matched cells eventually extravasate into the liver parenchyma [7] (Movie 1), and they do so in a yet undefined time frame after antigen recognition. This indicated not only that effector CD8 + T cell extravasation in the liver follows, rather than precedes, hepatocellular antigen recognition, but also that in this organ antigen recognition is a prerequisite for extravasation to occur. Efforts to systemically characterize CD8 + T cell extravasation as well as to explore the fate of extravascular T cells are ongoing.
Future directions
The abovementioned findings describe effector CD8 + T cell dynamics in the non-cancerous, HBVreplicating liver. This organ, however, represents a frequent site for primary neoplastic transformation, particularly in the context of chronic HBV infection [26] . Among primary liver cancers, hepatocellular carcinoma (HCC) accounts for up to 90% of all cases and is the third leading cause of cancer-related death worldwide [27] . How the anatomical, hemodynamic and environmental cues that characterize HCC influence CD8 + T cell behavior and function is currently a major focus of our laboratory. Pertinent to this, it is worth reminding that the normal liver is composed of functional units (i.e., lobules) where hepatocytes are organized in one-cell thick plates and where the basolateral side of each hepatocyte is in direct contact with highly fenestrated and basement
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membrane-less sinusoids that form the organ microcirculation [28] . Liver sinusoids are 200-250 lm in length and 7-15 lm in diameter and receive a dual blood supply from both the portal vein and the hepatic artery [28] . By contrast, HCC is characterized by a disrupted liver plate architecture where neoplastic hepatocytes are often organized in multilayer trabecular cords, so that many of these cells are distant and not in direct contact with the liver microvasculature [29] . Further, HCC usually develops its blood supply predominantly from the arterial system (a process referred to as arterialization) due to its high requirement for oxygen during progression [29] . Another neoangiogenic process characteristic of HCC is the socalled sinusoidal capillarization [29] . This process involves the progressive loss of sinusoidal fenestrae coupled with the collagenization of the space of Disse (i.e., the deposition of extracellular matrix between endothelial cells and hepatocytes [29] ). Capillarized sinusoids can be distinguished from the normal sinusoidal endothelium by the expression of CD34 and the absence of LYVE-1 [29] . One hypothesis that we are currently pursuing in the lab, thanks to the recent establishment of a novel HCC model that recapitulates most of the abovementioned features and is suitable for intravital microscopy studies, is that the anatomical, hemodynamic and environmental changes that characterize HCCs render neoplastic hepatocytes less susceptible to immunosurveillance by CD8 + T cells.
Moreover, the findings summarized in Fig. 2 reflect the behavior of Ag-experienced effector cells and they may not reflect what occurs in immunologically naïve hosts infected with a virus, like HBV, that replicate exclusively and non-cytopathically in hepatocytes [8] . Recently published data suggest that, if hepatic HBV gene expression precedes the generation of HBV-specific T cell precursors as it does during neonatal HBV infection, priming of naïve CD8 T cells occurs in the liver and this event induces functionally defective T cell responses [3] . We are currently taking advantage of dynamic imaging to further define intrahepatic T cell priming events and to elucidate the mechanisms responsible for the functional deficiency.
Conclusions
Many challenges remain in developing efficacious immunotherapies for chronic hepatic infections and liver cancers. Further advances in the field will strongly depend on additional elucidation of the mechanisms whereby CD8 + T cells exert their immune surveillance within the liver. We predict that intravital imaging-based strategy of dynamically visualizing CD8 + T cells in situ will generate novel mechanistic insights into the cellular and molecular determinants orchestrating hepatic immune responses. This new knowledge will provide muchneeded insight into aspects of adaptive immunity that may lead to novel, rational immunotherapies for chronic hepatic infections and liver cancers.
